Study to Evaluate the Safety and Clinical Outcome of Using Navigation System in Pedicle Screw Placement in Spine Surgery

November 9, 2022 updated by: Taipei Veterans General Hospital, Taiwan

A Two-arm, Single Center, Randomised Study to Evaluate the Safety and Clinical Outcome of Using Navigation System in Pedicle Screw Placement in Spine Surgery

The research project is testing whether in screw insertion of spine surgery using "Anatase" Spine Surgery Navigation System is at least as safe and accurate as using O-arm assisted spine surgery- Medtronic Stealthstation S7 Treatment Guidance System.

Study Overview

Detailed Description

Pedicle screw insertion is performed to treat the patients with spine conditions, including degenerative, traumatogenic, and neoplastic lesions. Accurate insertion of pedicle screw is a crucial step which directly affects the surgical outcomes. In order to place the screws safely and accurately, various conventional techniques have been used, focusing on marking anatomical locations, entry points and insertion angles. Since the early 1990, the methods using computer systems that allow real-time image processing have been explored in order to improve the accuracy of pedicle screw placement.

The Medtronic StealthStation® S7® System is a hardware platform that enables real-time surgical navigation using radiological patient images. The application software reformats patient-specific CT or MR images acquired before surgery, or fluoroscopic images acquired during surgery, and displays them on-screen from a variety of perspectives. The "Anatase" Spine Surgery Navigation System is indicated for precisely positioning of surgical instruments and/or implants during general spinal surgery, such as pedicle screw placement.

This study will be a two-arms, single center, evaluator blind, controlled, parallel, randomised study in patients with pedicle screw placement in spine surgery. This trial will include patients need to undergo pedicle screw placement surgery with indication of spinal tumor, traumatic injury or degenerative spine disease (Pedicle screws placed from 10th thoracic vertebra to first sacrum), who are ≥20 years and ≤80 years of age with Body Mass Index (BMI) < 40 kg/m2 and Spine T-Score ≥ -2.5.

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • Taipei Veterans General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients who need to undergo pedicle screw placement surgery with indication of spinal tumor, traumatic injury or degenerative spine disease.
  2. Pedicle screws placed from 10th thoracic vertebra to first sacrum.
  3. Age ≥20 years and ≤80 years.
  4. Body Mass Index (BMI) < 40 kg/m2.
  5. Spine T-Score by Dual Energy X-ray Absorptiometry ≥ -2.5, 60 days prior to surgery.
  6. The subject is willing and able to comply with the procedure and requirements of this trial.
  7. The participant is able to understand and provide informed consent, and has signed their written informed consent in accordance with IRB requirements.

Exclusion Criteria:

  1. Pregnant women.
  2. Hereditary or acquired haemorrhagic diathesis or coagulation factor deficiency.
  3. Be on uncontrolled Diabetes mellitus.
  4. Any history of stroke within the previous 6 months.
  5. Any history or current evidence suggestive of Coronary Artery Disease or Cerebral Vascular Accident within the previous 6 months, including clinical, EKG, laboratory, or imaging findings.
  6. Any terminal illness such that the patient would not be expected to survive more than 6 months.
  7. Creutzfeldt-Jakob disease.
  8. Known allergy to stainless steel (device material).
  9. Have a systematic or local infection, which may increase study risk.
  10. Immunocompromised such as but not limited to Acquired Immunodeficiency Syndrome (AIDS), HIV infection, Severe Combined Immunodeficiency Syndrome, Thymic Hypoplasia.
  11. Immunologically suppressed, or has received systemic steroids, excluding nasal steroids, at any dose daily for > 1 month within last 12 months.
  12. Any condition that, in the judgment of the investigator, could impose hazards to the patient if study therapy is initiated or affect the participation of the patient in the study.
  13. Former spinal surgery may interfere with the present trial.
  14. Participation in any investigational study in the last 30 days or current enrolment in any trial. Non- interventional Studies are not considered exclusion.
  15. Any condition that increases anesthesia risk.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: "Anatase" Spine Surgery Navigation System
Using "Anatase" Spine Surgery Navigation System in pedicle screw placement in spine surgery
using navigation system in pedicle screw placement in spine surgery
Active Comparator: Medtronic Stealthstation S7 Treatment Guidance System
Using Medtronic Stealthstation S7 Treatment Guidance System in pedicle screw placement in spine surgery
using navigation system in pedicle screw placement in spine surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of screw outside the vertebral body
Time Frame: not later than discharge, up to 14 days
Rate of screw outside the vertebral body as measure by post CT image which perform not later than discharge.
not later than discharge, up to 14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference between the actual and virtual (navigation image) of screw's sharp point position
Time Frame: not later than discharge, up to 14 days
Blind Assessor will measure the distance (mm) between the actual (post-CT) and virtual (baseline CT) of screw's sharp point position.
not later than discharge, up to 14 days
Difference between the actual and virtual (navigation image) angle of screws
Time Frame: not later than discharge, up to 14 days
Blind Assessor will measure the difference of angle (°) between the actual (post-CT) and virtual (baseline CT)screws.
not later than discharge, up to 14 days
Blood loss during surgery (mL)
Time Frame: operation 1 day
record the blood loss during surgery (mL)
operation 1 day
Total intraoperative radiation exposure for the operator and patient
Time Frame: 1 day, the TLD badges will be detected
Record the total intraoperative radiation exposure of operator and patient wearing TLD badges
1 day, the TLD badges will be detected
Mean time required for preparation of screw placement (min)
Time Frame: operation 1 day
Record the mean time required for preparation of screw placement (min)
operation 1 day
Time to accomplish each screw insertion (min)
Time Frame: operation 1 day
Record the time to accomplish each screw insertion (min)
operation 1 day
Ratio of revision surgery within 3 months after main surgery
Time Frame: after 3 months of surgery
Record ration of revision surgery within 3 months after main surgery
after 3 months of surgery
Length of postoperative hospital stay
Time Frame: Discharge day, up to 14 days
Record length of postoperative hospital stay
Discharge day, up to 14 days
Adverse event (AE) and serious AE (SAE) incidence rates during the trial
Time Frame: 90 days
Record Adverse event (AE) and serious AE (SAE) during the trial
90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tsung-Hsi Tu, Taipei Veterans General Hospital, Taiwan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 29, 2020

Primary Completion (Actual)

June 3, 2022

Study Completion (Actual)

August 31, 2022

Study Registration Dates

First Submitted

August 20, 2020

First Submitted That Met QC Criteria

September 30, 2020

First Posted (Actual)

October 8, 2020

Study Record Updates

Last Update Posted (Actual)

November 10, 2022

Last Update Submitted That Met QC Criteria

November 9, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Tumor

Clinical Trials on "Anatase" Spine Surgery Navigation System

3
Subscribe